CNH Partners »

Alnylam Pharmaceuticals shares owned by CNH Partners

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by CNH Partners from 13F filings

Historical chart of CNH Partners investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by CNH Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by CNH Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.3M 26k 274.80

More positions owned by CNH Partners

Endeavor Group Hldgs Cl A Com (EDR)
Southwestern Energy Company
American Airls Put Option (AAL)
Stride Note 1.125% 9/0 (Principal)
American Airlines Group Note 6.500% 7/0 (Principal)
Microstrategy Cl A New Put Option (MSTR)
Championx Corp (CHX)
Sea Sponsord Ads Put Option (SE)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Macom Tech Solutions Hldgs I Note 0.250% 3/1 (Principal)
Dropbox Note 3/0 (Principal)
Zscaler Note 0.125% 7/0 (Principal)
Axonics Modulation Technolog (AXNX)
Interdigital Note 3.500% 6/0 (Principal)
Transocean Deb 4.625% 9/3 (Principal)

View all positions for CNH Partners

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals